Clinical trial
A Post-Marketing, Observational, Comparative Safety Study of the Novartis Pandemic Influenza A (H1N1) Vaccine(s) in Pregnant Women Versus Non-Vaccinated Pregnant Women
NCT01037829 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Marketing, Observational, Comparative Safety Study of the Novartis Pandemic Influenza A (H1N1) Vaccine(s) in Pregnant Women Versus Non-Vaccinated Pregnant Women
- Lead sponsor
- Novartis Vaccines
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- November 30, 2010
- Enrollment
- 4,529 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
influenza